ArticleCurrent oncology (Toronto, Ont.)2026

Concurrent Chemoradiotherapy with Daily Low-Dose Carboplatin in Older Patients with Unresectable Locally Advanced Non-Small-Cell Lung Cancer: Clinical Outcomes and Prognostic Significance of Systemic Inflammation Markers.

Yu Miura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.